Sanara MedTech, Inc. SMTI 深 沪
等待开盘 02-11 09:30:00 美东时间
20.03
+0.110
+0.55%
华盛通- 最 高20.20
- 今 开19.99
- 成交量 1.30万股
- 最 低 19.60
- 昨 收 19.92
- 总市值 1.79亿
- 52周最高 36.3098
- 市盈率 静 --
- 换手率 0.15%
- 52周最低 18.90
- 委 比 -26.90%
- 总股本 893.57万
- 历史最高 53.85
- 量 比 0.44
- 振 幅 3.01%
- 历史最低 17.41
- 每 手 1
- 风险率 4.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
HC Wainwright & Co. Reiterates Buy on Sanara MedTech, Maintains $36 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Sanara MedTech (NASDAQ:SMTI) with a Buy and maintains $36 price target.
01-27 02:40
Sanara MedTech Expects Q4 Revenue To Be $27.2M-$27.7M, Up ~3%-5%, Compared To $26.3M In Q4 Of 2024
Sanara MedTech Inc. ("Sanara MedTech," "Sanara," the "Company," "we," "our" or "us") (NASDAQ:SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical
01-23 20:34
Sanara MedTech's BIASURGE Advanced Surgical Solution Product Receives Innovative Technology Contract From Vizient
Contract awarded for products that bring improvement to the healthcare industryFORT WORTH, TX, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara MedTech," "Sanara," the "Company," "we," "our" or "us")
01-08 05:09
Sanara MedTech And Biomimetic Innovations Advance Strategic Alliance; Sanara Reaffirms Plans To Launch OsStic Bio‑Adhesive To US Commercial Market In Q1 2027
Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic's granted patent in 2025FORT WORTH, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," the "Company,"
2025-12-10 21:44
Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd
Sanara MedTech Inc. announced its participation in the Piper Sandler 37th Annual Healthcare Conference, where management will present on December 3, 2025. Presentation materials and a live webcast will be available on the Company’s investor relations website. Sanara develops surgical products to improve outcomes and reduce costs in the surgical market.
2025-11-19 12:30
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 176.6% to $1.21...
2025-11-13 01:05
Sanara MedTech Q3 EPS $(3.40) Misses $(0.21) Estimate, Sales $26.334M Miss $26.625M Estimate
Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(3.40) per share which missed the analyst consensus estimate of $(0.21) by 1481.4 percent. This is a 900 percent decrease over losses of $(0.34) per share from
2025-11-12 20:03
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
2025-11-12 19:11
